Kevin Weil's Warp Sciences Exits Stealth With $215M at $865M to Automate US Drug-Variant Labs

Warp Sciences launched Oct 22 with $215M at an $865M post-money valuation led by Lightspeed, with IVP, Premji Invest and Lux Capital participating. Kevin Weil, formerly OpenAI's AI-for-science head, co-founded it with DJ Patil, ex-Meta Superintelligence VP Manohar Paluri, and Solomon Reisberg. Angels include Sarah Friar, Brian Armstrong and Reid Hoffman. The company is building a US robotics-and-AI lab for the drug-variant optimization work now outsourced to Chinese CROs like WuXi AppTec.